Insider buying
~$7.8K9,670 sh @ $0.8024
Traded Dec 15, 2025 · filed 2 days later
The CEO of 60 Degrees Pharmaceuticals paid $7.8K out of pocket for 60 Degrees Pharmaceuticals shares. Shares held went up 19% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 10, 2025 · Filed Dec 12, 2025
The CEO of 60 Degrees Pharmaceuticals paid $8.9K out of pocket for 60 Degrees Pharmaceuticals shares. Shares held went up 25% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$8,886
Shares × reported transaction price
<$25K
+25.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $3.76 on Dec 10, 2025, within 4% of its 52-week low, after a 34% drop over the previous 30 trading days
52-week range $3.64 (Nov 14, 2025) to $44.20 (Dec 11, 2024), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $5.68 on Oct 28, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.0% | +0.6% | −4.6% |
| 30 days | −41.8% | +1.4% | −43.3% |
| 90 days | −31.4% | −1.7% | −29.7% |
| 180 days | −54.6% | +10.9% | −65.5% |
Past results only. Not a forecast.
Insider buying
Traded Dec 15, 2025 · filed 2 days later
The CEO of 60 Degrees Pharmaceuticals paid $7.8K out of pocket for 60 Degrees Pharmaceuticals shares. Shares held went up 19% with this purchase.
Insider buying
Traded Dec 11, 2025 · filed 1 day later
The CEO of 60 Degrees Pharmaceuticals paid $3.3K out of pocket for 60 Degrees Pharmaceuticals shares. Shares held went up 8% with this purchase.
Geoffrey S Dow, President and CEO's past purchases, 90 days after disclosure: 5 buys, median −39.9 pts vs S&P 500, beat it 0 of 5 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.